Docoh
Loading...

MDWD MediWound

MediWound is a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Its strategy is centered around its validated enzymatic platform technology, focused on next-generation bio-active therapies for burn and wound care and biological medicinal products for tissue repair.

MDWD stock data

(
)

Calendar

25 Feb 21
27 Oct 21
31 Dec 21
Quarter (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from MediWound earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

19.3% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 25 28 -10.7%
Opened positions 7 26 -73.1%
Closed positions 10 0 NEW
Increased positions 7 0 NEW
Reduced positions 8 1 +700.0%
13F shares
Current Prev Q Change
Total value 19.95M 53.96M -63.0%
Total shares 5.27M 6.59M -20.0%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Rosenberg Lior 1.71M $6.33M 0.0%
Migdal Insurance & Financial 1.2M $4.58M -22.0%
Uniplan Investment Counsel 477.96K $1.83M NEW
Renaissance Technologies 473.72K $1.81M -31.6%
Sargent Investment 333.75K $1.28M -8.5%
WFC Wells Fargo & Co. 266.53K $1.02M +0.7%
Acadian Asset Management 252.67K $968K -6.9%
Wellington Management 192.12K $736K -6.3%
MS Morgan Stanley 76.45K $293K +88.5%
JPM JPMorgan Chase & Co. 66.58K $255K +47.7%
Largest transactions
Shares Bought/sold Change
Parian Global Management 0 -688.98K EXIT
Uniplan Investment Counsel 477.96K +477.96K NEW
Migdal Insurance & Financial 1.2M -337.71K -22.0%
Essex Investment Management 0 -331.39K EXIT
Bokf, Na 0 -249.96K EXIT
Renaissance Technologies 473.72K -218.93K -31.6%
Millennium Management 0 -44.83K EXIT
BLK Blackrock 44.39K +42.15K +1885.2%
MS Morgan Stanley 76.45K +35.9K +88.5%
Sargent Investment 333.75K -31K -8.5%

Financial report summary

?
Competition
Marizyme
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: abnormal, Actinic, additioanl, Adjunct, AK, AKs, API, archer, Armory, astrategy, Atrium, aviation, BA, Baltic, Barry, BCC, Biden, bilateral, bioactive, biofilm, biopharma, BMS, book, Bowen, Bulgaria, cancer, CAPEX, carcinoma, Cardiff, chain, civilian, clearance, collagenase, CPRA, crest, currantly, cybersecurity, David, decade, deployment, DETCET, downtime, encompassing, exacerbated, expiry, flat, Flom, forecasted, forging, Fox, frail, France, genital, genitalia, Greece, hedgehog, histological, histologically, honorary, imiquimod, ineligible, infrequently, inoperable, Instruction, Iranian, Kirkland, lawfully, Leashold, lesion, lump, Luxemburg, Malta, mathematical, Meagher, mediated, micrographic, Moed, neighboring, nodular, outer, oversaw, Oxley, pace, pandemic, Park, PDUFA, peace, persistence, photoexposed, platform, porcine, Portugal, precise, prioritization, prioritizing, ratified, reconsider, regeneration, remote, remotely, rescinded, resection, resume, resumption, rocket, Romandie, ROU, sabotage, SCC, shelter, shot, situ, Skadden, Slate, solar, sophisticated, sophistication, southern, spread, Squibb, straightforward, summer, sun, TASE, TelAviv, trajectory, tumor, ultraviolet, uncontrolled, upper, USA, UV, vast, virtual, Visiting, workforce
Removed: abide, accumulation, Africa, allege, analgesia, anemia, antibacterial, applicability, autografted, BOQ, Boston, bringing, buyout, Cohen, collaborate, Concurrent, contracted, contractually, contracture, cumulatively, detected, detrimental, dispositive, Egypt, Eisenstrasse, explore, extract, graft, headcount, height, implied, insomnia, invested, itching, Lapidot, line, MA, mentioned, minimization, nausea, observational, occurring, opening, organism, par, pharmacokinetic, pigmentation, pliability, practiced, precautionary, preventive, proportion, proposal, pyrexia, questionnaire, receivable, remeasured, revalued, routinely, score, slightly, soaking, Spain, spent, stability, stopping, straight, suggesting, sweeping, systemically, talented, targeting, thirty, transient, unrest, Vancouver, vascularity, violence, vomiting, Wellington, Yelin

Proxies

No filings